Establishment Labs Expands Geographic Footprint: Launches Motiva Implants® in Thailand
Establishment Labs officially launched its Motiva SmoothSilk®/SilkSurface™ Round Implants and Motiva Ergonomix™ Implants last month in Thailand, one of the largest breast aesthetic markets in Asia, according to the International Society of Aesthetic Plastic Surgery.
At a special event held in Bangkok on the Science of Breast Tissue Management on May 29th, organized in conjunction with the Thai Society of Plastic and Reconstructive Surgery, the Chief Executive Officer of Establishment Labs, Juan José Chacón-Quirós, gave a keynote speech, entitled, “How Ergonomy Is Transforming Breast Aesthetics.”
According to Dr. Apirag Chuangsuwanich, President of the Thai Society of Plastic and Reconstructive Surgery, “It is an innovative device, and we look forward to providing this technology to Thai patients undergoing breast augmentation, revision and reconstruction.”
Establishment Labs’ expansion in Thailand marks the Company’s progress on its commitment to women’s health. Establishment Labs was founded to bring patients a safer choice in breast surgery with improved aesthetic outcomes. With Motiva Implants® now commercially available in over 70 countries worldwide, Establishment Labs continues to deliver much needed innovation in breast aesthetics and reconstruction to more patients across the globe.
For more information about Motiva Implants®, please visit motiva.health.
 International Society of Aesthetic Plastic Surgery, “ISAPS International Survey on Aesthetic/Cosmetic Procedures Performed in 2017.”